These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 2886649

  • 1. Local and neurally mediated effects of sufentanil on canine skeletal muscle vascular resistance.
    O'Keefe RJ, Domalik-Wawrzynski L, Guerrero JL, Rosow CE, Lowenstein E, Powell WJ.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):699-706. PubMed ID: 2886649
    [Abstract] [Full Text] [Related]

  • 2. Neurogenic histaminergic vasodilation in canine skeletal muscle: mediation by alpha 2-adrenoceptor stimulation.
    Camazine B, Shannon RP, Guerrero JL, Graham RM, Powell WJ.
    Circ Res; 1988 May; 62(5):871-83. PubMed ID: 3359574
    [Abstract] [Full Text] [Related]

  • 3. Local and neurally mediated effects of morphine on skeletal muscle vascular resistance.
    Lowenstein E, Whiting RB, Bittar DA, Sanders CA, Powell WJ.
    J Pharmacol Exp Ther; 1972 Feb; 180(2):359-67. PubMed ID: 4400891
    [No Abstract] [Full Text] [Related]

  • 4. Decrease in vascular resistance in the isolated canine hindlimb after graded doses of alfentanil, fentanyl, and sufentanil.
    White DA, Reitan JA, Kien ND, Thorup SJ.
    Anesth Analg; 1990 Jul; 71(1):29-34. PubMed ID: 2141970
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the role of alpha-1 and alpha-2 adrenoceptors in the maintenance of neurogenic tone to the hindlimb vasculature.
    Hamed AT, Jandhyala BS, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):599-605. PubMed ID: 3016243
    [Abstract] [Full Text] [Related]

  • 6. Intravenous administration of lenperone and glycopyrrolate followed by continuous infusion of sufentanil in dogs: cardiovascular effects.
    Benson GJ, Thurmon JC, Tranquilli WJ, Corbin JE.
    Am J Vet Res; 1987 Sep; 48(9):1372-5. PubMed ID: 2959181
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I, Lorrain J, Di Paola ED, Lhoste F, Payen B, Dennis T, Scatton B.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [Abstract] [Full Text] [Related]

  • 8. Effect of intracarotid administration of ouabain in dogs.
    Lopez JA, Timmis AD, Garan H, Homcy CJ, Powell WJ.
    Am J Physiol; 1988 Jan; 254(1 Pt 2):H148-55. PubMed ID: 3337251
    [Abstract] [Full Text] [Related]

  • 9. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    Grega GJ, Barrett RJ, Adamski SW, Lokhandwala MF.
    J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of nicotine in canine skeletal muscle.
    Crystal GJ.
    Proc Soc Exp Biol Med; 1991 Apr; 196(4):421-7. PubMed ID: 1672564
    [Abstract] [Full Text] [Related]

  • 11. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J.
    Acta Physiol Scand Suppl; 1988 Apr; 568():1-56. PubMed ID: 3232527
    [Abstract] [Full Text] [Related]

  • 12. Effect of systemic endotoxin on skeletal muscle vascular conductance during high and low adrenergic tone.
    Bond RF, Scott CG, Clevenger JC, Bond CH, Abel FL.
    Circ Shock; 1990 Apr; 30(4):311-22. PubMed ID: 2190711
    [Abstract] [Full Text] [Related]

  • 13. Neural effect of digitalis glycosides on gracilis vascular resistance in hypotension.
    Garan H, Powers ER, Ruskin JN, Powell WJ.
    Am J Physiol; 1980 May; 238(5):H729-39. PubMed ID: 7377367
    [Abstract] [Full Text] [Related]

  • 14. Interactions between histaminergic and cholinergic pathways of gastric motility regulation.
    Milenov K, Todorov S, Vassileva M, Zamfirova R, Shahbazian A.
    Methods Find Exp Clin Pharmacol; 1996 May; 18(1):33-9. PubMed ID: 8721254
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
    Lokhandwala MF, Kivlighn SD, Jandhyala BS.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
    [Abstract] [Full Text] [Related]

  • 16. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ, Haitsma DB, van der Geest IE, Stubenitsky R, van Meegen JR, Man in't Veld AJ, Verdouw PD.
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [Abstract] [Full Text] [Related]

  • 17. Morphine, opioids, and the feline pulmonary vascular bed.
    Kaye AD, Hoover JM, Kaye AJ, Ibrahim IN, Fox C, Bajwa A, Anwar M, Fields AM, Baluch A, Huffman S, Chilian W.
    Acta Anaesthesiol Scand; 2008 Aug; 52(7):931-7. PubMed ID: 18477088
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of action of prostaglandin E2 in the dog skeletal muscle circulation.
    Ballard HJ, Achike FI.
    Chin Med J (Engl); 1998 Oct; 111(10):945-50. PubMed ID: 11189246
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
    Hom GJ, Jandhyala BS.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.